Fukada, I., Ito, Y., Kobayashi, K., Shibayama, T., Takahashi, S., Horii, R., . . . Ohno, S. (2017). The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel. PLoS One.

Fukada, Ippei, Yoshinori Ito, Kokoro Kobayashi, Tomoko Shibayama, Shunji Takahashi, Rie Horii, Futoshi Akiyama, Takuji Iwase, und Shinji Ohno. "The Early Onset of Peripheral Neuropathy Might Be a Robust Predictor for Time to Treatment Failure in Patients With Metastatic Breast Cancer Receiving Chemotherapy Containing Paclitaxel." PLoS One 2017.

Fukada, Ippei, et al. "The Early Onset of Peripheral Neuropathy Might Be a Robust Predictor for Time to Treatment Failure in Patients With Metastatic Breast Cancer Receiving Chemotherapy Containing Paclitaxel." PLoS One 2017.